PRPL NASDAQ
Purple Innovation, Inc.
1W: -13.8%
1M: -44.4%
3M: -76.2%
YTD: +195.8%
1Y: +132.7%
3Y: +41.1%
5Y: -90.5%
$2.10
-0.03 (-1.41%)
Weekly Expected Move ±21.1%
$1
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (44)
Can Kimberly-Clark's Arbex JV Strengthen Global Personal Care Focus?
Can Kimberly-Clark's Pricing Actions Offset Rising Input Cost Risks?
HAIN's Q4 Loss Wider Than Expected, Sales Beat Estimates
Can Kimberly-Clark's North America Business Accelerate in Second Half?
Can Cost Savings Offset Inflation & Protect Clorox's Margins?
Can Kimberly-Clark's Innovation Pipeline Power Its Next Growth Phase?
Can Kimberly-Clark's Productivity Offset Inflationary Pressures?
Can Kimberly-Clark's Powering Care Strategy Sustain Growth Momentum?
Purple (PRPL) Q2 2026 Earnings Call Transcript
Purple forecasts $20M-$25M FY2026 adjusted EBITDA as revenue guide lowered to $420M-$440M
Purple Innovation (PRPL) Reports Q2 Loss, Misses Revenue Estimates
Earnings Preview: BBB Foods (TBBB) Q2 Earnings Expected to Decline
Energizer Q3 Earnings Miss Estimates on Margin & Mix Pressure
Clorox Q4 Earnings & Sales Top Estimates as GOJO Supports Sales
Purple Innovation (PRPL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session
Albertsons Bets on Curbside Pharmacy to Drive Customer Growth
After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for Purple Innovation (PRPL)
This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
Purple Innovation Q1 2026 Earnings Call Transcript
Purple Innovation misses Q1 estimates, lowers FY guidance
11 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Purple Innovation Reports First Quarter 2026 Results
Earnings Scheduled For April 28, 2026
Here are the major earnings before the open Tuesday
Procter & Gamble Q3 Earnings Beat on Volume-Led Organic Sales Growth
Newell Brands (NWL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Kimberly-Clark's New Structure Sets Stage for Kenvue Integration
PRPL Q4 Loss Narrower Than Estimates, Sales Rise on Wholesale Strength
Purple projects $500M-$520M 2026 revenue with $20M-$30M adjusted EBITDA, backed by Mattress Firm and Costco expansion
Purple Innovation (PRPL) Reports Q4 Loss, Tops Revenue Estimates
12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session
Purple Innovation beats top-line and bottom-line estimates; gives Q1 and FY26 outlook
Purple Innovation Reports Fourth Quarter and Full Year 2025 Results
Purple Innovation Reports Fourth Quarter and Full Year 2025 Results
Earnings Scheduled For March 31, 2026
Here are the major earnings before the open Tuesday
Purple Innovation Q4 2025 Earnings Preview
Purple Innovation to Report Fourth Quarter and Full Year 2025 Results on March 25, 2026
Smithfield Foods, Inc. (SFD) Tops Q4 Earnings and Revenue Estimates
Head to Head Analysis: Reborn Coffee (NASDAQ:REBN) vs. Purple Innovation (NASDAQ:PRPL)
Independent studies show Purple Innovations® Essential and Restore mattresses, with GelFlex Grid® technology, show self-reported pain dropping by 63-68% and sleep quality and comfort significantly improving
Contrasting Purple Innovation (NASDAQ:PRPL) and Inspire Veterinary Partners (NASDAQ:IVP)